Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q4 FY26
Discovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
129.30 | 693 Cr | 187.30 | 2.36 | 0.00 | 1.97 | 5.07 | 0.69 | ||
283.70 | 657 Cr | 31.98 | 6.52 | 0.00 | 20.38 | 27.21 | 0.00 | ||
184.15 | 644 Cr | 22.04 | 2.30 | 0.00 | 10.79 | 12.00 | 6.38 | ||
113.98 | 619 Cr | 38.69 | 1.99 | 0.00 | -1.05 | 0.74 | 3.45 | ||
333.35 | 572 Cr | 123.74 | 24.49 | 0.00 | 19.79 | 23.50 | 10.61 | ||
841.00 | 483 Cr | 21.39 | 1.23 | 0.59 | -0.38 | 0.75 | 4.35 | ||
1055.20 | 466 Cr | 14.18 | 2.36 | 1.96 | 17.63 | 23.20 | 14.53 | ||
| Median: 7 Co. | — | 283.70 | 619 Cr | 31.98 | 2.36 | 0.00 | 10.79 | 12.00 | 4.35 |
Pharmaceuticals & Biotechnology
Pharmaceuticals
572 Cr
Low Risk
123.7
37.7
—
24.5
340.00
32.32
Sales CAGR
Profit CAGR
ROE
ROCE
Aptus Pharma Ltd (APPL) is currently trading at 340.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aptus Pharma Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Aptus Pharma Ltd has traded between a low of ₹32.32 and a high of ₹340.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aptus Pharma Ltd has a market capitalization of approximately 571.70. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aptus Pharma Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 123.74 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 571.70 Cr, Aptus Pharma Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aptus Pharma Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aptus Pharma Ltd is 123.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The board approved a preferential allotment of 16,02,870 equity shares at ₹280 per share, raising ₹44.88 crore, and also approved convening the 16th AGM on September 14, 2026.
They approved a 3:2 bonus share issue and an increase in authorised share capital from ₹7.15 crore to ₹25.00 crore, with 100% votes in favour.
Bearish
5
Neutral
4
Bullish
5
Bearish
5
Neutral
4
Bullish
37
Bearish
0
Neutral
0
Bullish
32
Bearish
5
Neutral
4
Bullish
5
Bearish
5
Neutral
4
Bullish
5
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
